Showing results (441-450 of 470) with videos related to
Sort By:
Pageof 47
Human Brain Mapping|September 9, 2021
A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA ConsortiumBoris A Gutman, Theo G M van Erp, Kathryn Alpert, et al.The American Journal of Psychiatry|June 24, 2026
Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based SamplesJennifer K Forsyth, Jinhan Zhu, Ariana S Chavannes, et al.Social Psychiatry and Psychiatric Epidemiology|January 5, 2021
The association between migrant status and transition in an ultra-high risk for psychosis populationBrian O'Donoghue, Hellen Geros, Holly Sizer, et al.Schizophrenia (Heidelberg, Germany)|June 6, 2025
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measuresDaniel H Mathalon, Spero Nicholas, Brian J Roach, et al.Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Shared genetic architecture of brain age gap across 30 cohorts worldwideVilte Baltramonaityte, Philippe Jawinski, Marlene Staginnus, et al.JAMA Psychiatry|May 5, 2021
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis, Maria Jalbrzikowski, Rebecca A Hayes, et al.Schizophrenia Bulletin|August 3, 2026
Processing Speed and Verbal Learning Ability as Predictors of Assessor-Rated and Ecological Momentary Assessment Self-Reported Functioning: Findings from AMP SCZDanielle N Pratt, Kathryn E Lewandowski, Hannah Hacker, et al.Schizophrenia (Heidelberg, Germany)|April 3, 2025
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia ProgramNora Penzel, Pablo Polosecki, Jean Addington, et al.Molecular Psychiatry|February 9, 2024
Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-riskYinghan Zhu, Norihide Maikusa, Joaquim Radua, et al.Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.Pageof 47